Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Semprae Laboratories Inc.

Division of Innovus Pharmaceuticals Inc.
www.semprae.com

Latest From Semprae Laboratories Inc.

Deals Shaping The Medical Industry, February 2014

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced December 2013 through January 2014.

BioPharmaceutical Medical Device

In Brief: warning letters, UrgentRx OTCs fly, Innovus acquires Semprae

GMPs apply despite product discontinuation; format renders spray products drugs; Rogaine label clarified; UrgentRx OTCs take flight; Innovus acquires Semprae; Omega Protein closes plant; FDA evaluates consumer communication; and EU vitamin, mineral, botanical sales outpace forecast.

Consumer Canada

In Brief: warning letters, UrgentRx OTCs fly, Innovus acquires Semprae

GMPs apply despite product discontinuation; format renders spray products drugs; Rogaine label clarified; UrgentRx OTCs take flight; Innovus acquires Semprae; Omega Protein closes plant; FDA evaluates consumer communication; and EU vitamin, mineral, botanical sales outpace forecast.

Consumer Canada
See All

Company Information

  • Industry
  • Biotechnology
    • Drug Discovery Tools
      • Molecular Diversity
        • Natural Products
  • Pharmaceuticals
    • Drug Delivery
      • Topical Delivery
    • OTC, Consumer
  • Therapeutic Areas
  • Gynecological, Urological
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Innovus Pharmaceuticals Inc.
  • Senior Management
  • Mary Wallace Jaensch, CEO
  • Contact Info
  • Semprae Laboratories Inc.
    Phone: (201) 518-8200
    160 Pehle Ave. Park 80 East
    Ste. 301
    Saddle Brook, NJ 07663
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register